Early growth patterns of methadone-addicted infants

Area of Science:

• Neonatal development
• Pharmacology
• Pediatric growth

Background:

• Neonatal Abstinence Syndrome (NAS) can impact infant development.
• Methadone hydrochloride maintenance is used to manage opioid use disorder during pregnancy.
• Understanding the long-term effects of prenatal methadone exposure on infant growth is crucial.

Purpose of the Study:

• To investigate the early growth patterns of infants exposed to methadone hydrochloride in utero.
• To correlate infant growth with the presence and resolution of neonatal withdrawal symptoms.
• To compare observed growth patterns with existing animal study data.

Main Methods:

• Longitudinal study of 15 full-term infants born to mothers on controlled, low-dose methadone therapy.
• Monitoring of anthropometric measurements (birth weight, length, head circumference) over the first 6 months.
• Clinical assessment of neonatal withdrawal symptoms and their duration.

Main Results:

• Infants exhibited below-average birth measurements (10th percentile for weight/length, 5th for head circumference).
• Growth parameters remained consistent with initial percentiles during the first 3-4 months of withdrawal symptoms.
• An accelerated growth pattern emerged between 4-6 months as withdrawal symptoms diminished.

Conclusions:

• Prenatal methadone exposure may lead to initial growth deficits in infants.
• Infant growth demonstrates catch-up development following the resolution of neonatal withdrawal symptoms.
• Observed accelerated growth in human infants aligns with findings from animal models of prenatal drug exposure.